Surgical Site Infection Control Market - Growth, Trends, and Forecast (2020 - 2025)
|出版商||Mordor Intelligence LLP||商品編碼||802343|
|出版日期||內容資訊||英文 118 Pages
|手術部位預防感染的全球市場:成長，趨勢，預測(2019∼2024年) Surgical Site Infection Control Market - Growth, Trends, and Forecast (2020 - 2025)|
|出版日期: 2020年08月01日||內容資訊: 英文 118 Pages||
Currently, the global SSI control market has been in a growing phase and is dominated by hospitals and developed regions, like North America. The increasing hospital-acquired infections and number of surgeries have been increasingly driving the SSI control market across the world.
Superficial Incisional SSI Segment is Expected to Exhibit Fastest Growth Rate Over the Forecast Period
Surgical site infection (SSI) represents the most common nosocomial infection and accounts for about 15% of all nosocomial infections. Surgical site infection is one of the most common complications of gastrointestinal surgery. This type of surgical procedures and wound closure methods affect the incidence of superficial incisional surgical site infection. There has been an increase in the incidence of superficial incisional SSI infections, as compared to deep incisional SSI and organ or space SSIs.
North America Captured the Largest Market Share and is Expected to Retain its Dominance
North America has been dominating the surgical site infection control market, with the United States contributing the largest share in the regional revenue. SSIs have been considered the most common (tied with pneumonia) healthcare-associated infection (HAI) among inpatients in acute care hospitals in the United States. SSIs occur in an estimated 2-5% of patients undergoing inpatient surgery. The estimated annual incidence of SSIs in the United States ranges from 160,000 to 300,000, and the estimated annual cost ranges from USD 3.5 billion to USD 10 billion. Hence, the rising need for the prevention of SSI can be attributed to the rising number of surgical procedures performed in the United States.
3M Company, Becton, Dickinson and Company, Biomerieux SA, Getinge Group, and Johnson & Johnson are some of the major players in the surgical site infection control market The competitive rivalry of the market studied has intensified, owing to the constant product innovations across the world.